Palisade Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +249.8% | -71.4% | +0.0% | +0.0% | +0.0% | +10,000.0% | -99.0% | +0.0% | +0.0% | +215.8% | -68.3% | +0.0% | +140.8% | -58.5% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +17,340.4% | -97.3% | +4.8% | +4.5% | +6.5% | -6.1% | -43.5% | +0.0% | +3.8% | -96.3% | +5,300.0% | -98.1% | +0.0% | +0.0% | +100.0% | -50.0% | +0.0% | – | – | – | – | – | |
| – | +0.0% | +249.8% | -71.4% | +0.0% | +0.0% | +0.0% | +10,000.0% | -99.0% | +0.0% | +0.0% | +215.8% | -68.3% | +0.0% | +140.8% | -58.5% | -4,220.0% | – | -461.0% | – | – | – | – | – | – | – | – | -110.8% | – | – | – | – | – | – | -150.0% | – | – | – | – | – | – | |
| – | +45.1% | +12.1% | -27.9% | -10.9% | -46.5% | -15.5% | -13.2% | -11.6% | -2.0% | +72.3% | -37.0% | -13.5% | +22.5% | +23.7% | -48.0% | -36.6% | +90.5% | -11.8% | -54.6% | +98.7% | +28.2% | +19.9% | +37.3% | +46.4% | +21.5% | -47.0% | +75.4% | -3.4% | -34.8% | +61.5% | +18.7% | -18.7% | -2.5% | -54.4% | +76.3% | -16.8% | +342.8% | +3.6% | +15.7% | – | |
| – | -2.3% | +22.9% | -18.5% | +22.8% | -26.2% | -2.1% | +6.7% | -5.8% | -21.8% | +1.7% | +2.9% | +33.9% | +63.7% | -46.3% | +4.2% | +17.9% | +75.2% | -48.7% | +92.3% | -1.4% | +34.9% | -9.2% | -23.0% | -8.0% | -27.5% | +2.2% | -6.9% | +16.9% | -6.9% | -6.4% | +8.5% | -8.0% | -10.9% | +4.8% | -14.1% | +30.8% | +149.2% | +14.3% | +10.3% | – | |
| – | +28.2% | +15.1% | -25.2% | -0.3% | -38.6% | -9.2% | -3.2% | -8.4% | -13.3% | +36.1% | -21.7% | +10.4% | +0.4% | +11.6% | -22.7% | -7.0% | +89.4% | -39.8% | +1,581.6% | -90.8% | +33.5% | -3.5% | -8.1% | +23.5% | -12.8% | -27.8% | +29.9% | +4.7% | -16.5% | +16.4% | +14.7% | -14.7% | -5.9% | -31.7% | +23.1% | +2.8% | +241.6% | +7.7% | +13.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -25.4% | -20.2% | -27.7% | -88.7% | -91.2% | +38.8% | -59.8% | +94.0% | +134.2% | -42.5% | -74.9% | +277.3% | +134.3% | -42.5% | +326.5% | +154.5% | +3,603.6% | +65.0% | -61.7% | -96.0% | -80.8% | -80.0% | +400.0% | -20.0% | -25.0% | +6,200.0% | -98.4% | +166.7% | -50.0% | -75.0% | +100.0% | +200.0% | -50.0% | -66.7% | +100.0% | +150.0% | -60.0% | -50.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -86.7% | -491.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -120.7% | – | -813.9% | – | – | -91.7% | +585.0% | -81.8% | +486.1% | -144.0% | – | -24.7% | -72.6% | -5,712.9% | – | – | +575.9% | +773.0% | -166.5% | – | -1,161.5% | – | -487.4% | – | – | – | – | -100.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -86.7% | -491.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -86.4% | -474.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.